Quercetin Mitigates Methamphetamine-Induced Anxiety-Like Behavior Through Ameliorating Mitochondrial Dysfunction and...

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Methamphetamine (MA) abuse is linked to neurotoxicity, including anxiety and depression.
• The precise mechanisms underlying MA-induced anxiety remain unclear.
• Mitochondrial dysfunction is increasingly implicated in psychiatric disorders.

Purpose of the Study:

• To investigate the role of mitochondrial dysfunction in MA-induced anxiety.
• To evaluate quercetin as a potential therapeutic agent for MA-induced anxiety.
• To elucidate the molecular pathways affected by MA and quercetin treatment.

Main Methods:

• Developed a mouse model of MA-induced anxiety-like behavior.
• Utilized RNA sequencing to analyze gene expression in the hippocampus.
• Assessed mitochondrial function (ROS, MMP, OCR, ATP) and neuroinflammation markers (IL-1β, TNFα, IL-6) in vitro and in vivo.
• Investigated the effects of quercetin on astrocyte activation.

Main Results:

• MA administration induced anxiety-like behavior and hippocampal gene expression changes linked to mitochondrial function.
• Quercetin treatment alleviated anxiety-like behavior and improved mitochondrial impairment in vivo.
• In vitro, quercetin restored mitochondrial function by reducing ROS and MMP, and increasing OCR and ATP production.
• Quercetin attenuated astrocyte activation and reduced specific neuroinflammatory markers (IL-1β, TNFα).

Conclusions:

• Methamphetamine induces anxiety-like behavior via mitochondrial dysfunction.
• Quercetin demonstrates antipsychotic effects by modulating mitochondrial function and neuroinflammation.
• Quercetin shows promise as a potential therapeutic strategy for methamphetamine-induced anxiety.